Keratinocyte growth factor stimulates growth of MIA PaCa-2 cells through extracellular signal-regulated kinase phosphorylation

Yamamoto,Tetsushi; Matsuda,Yoko; Kawahara,Kiyoko; Naito,Zenya; Ishiwata,Toshiyuki

doi:10.3892/ol.2011.466

Keratinocyte growth factor stimulates growth of MIA PaCa-2 cells through extracellular signal-regulated kinase phosphorylation

Authors:
- Tetsushi Yamamoto
- Yoko Matsuda
- Kiyoko Kawahara
- Zenya Naito
- Toshiyuki Ishiwata
View Affiliations

Affiliations: Departments of Pathology and Integrative Oncological Pathology, Nippon Medical School, Tokyo, Japan
Published online on: October 31, 2011 https://doi.org/10.3892/ol.2011.466
Pages: 307-310

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Keratinocyte growth factor (KGF), also known as fibroblast growth factor-7, is mainly synthesized by mesenchymal cells. KGF modulates proliferation, differentiation, migration and adhesion to extracellular matrices of epithelial cells that specifically express the KGF receptor (KGFR). We previously reported that KGF is expressed in cancer cells and adjacent stromal fibroblasts in human pancreatic cancer tissues. Furthermore, KGF is thought to stimulate the growth of certain pancreatic cancer cell lines. The aim of the present study was to examine whether the mitogen-activated protein kinase (MAPK) pathway contributes to exogenous KGF‑induced pancreatic cancer cell growth. Recombinant human KGF (rhKGF) was administered to MIA PaCa-2 cells, which expressed KGFR and negligible levels of KGF. Cell growth rates in MIA PaCa-2 cells were significantly increased in a dose-dependent manner following the addition of rhKGF. In the MAPK pathway, phosphorylation of extracellular signal‑regulated kinase (ERK) in MIA PaCa-2 cells was increased in a dose-dependent manner, and phosphorylation of p38 was slightly increased following the administration of 100 ng/ml rhKGF. In contrast, JNK was not phosphorylated following the addition of rhKGF in MIA PaCa-2 cells. U0126, a specific inhibitor of ERK activation, decreased the rhKGF‑induced phosphorylation of ERK and the growth rates of MIA PaCa-2 cells. These findings indicated that phosphorylation of the ERK signaling pathway plays a significant role in exogenous KGF-induced pancreatic cancer cell growth.

View Figures

View References

1	Rubin JS, Osada H, Finch PW, Taylor WG, Rudikoff S and Aaronson SA: Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci USA. 86:802–806. 1989. View Article : Google Scholar : PubMed/NCBI
2	Finch PW, Rubin JS, Miki T, Ron D and Aaronson SA: Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science. 245:752–755. 1989. View Article : Google Scholar : PubMed/NCBI
3	Brauchle M, Angermeyer K, Hubner G and Werner S: Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts. Oncogene. 9:3199–3204. 1994.PubMed/NCBI
4	Katoh M: Cancer genomics and genetics of FGFR2 (Review). Int J Oncol. 33:233–237. 2008.
5	Ornitz DM, Xu J, Colvin JS, et al: Receptor specificity of the fibroblast growth factor family. J Biol Chem. 271:15292–15297. 1996. View Article : Google Scholar : PubMed/NCBI
6	Elghazi L, Cras-Meneur C, Czernichow P and Scharfmann R: Role for FGFR2IIIb-mediated signals in controlling pancreatic endocrine progenitor cell proliferation. Proc Natl Acad Sci USA. 99:3884–3889. 2002. View Article : Google Scholar : PubMed/NCBI
7	Miki T, Bottaro DP, Fleming TP, et al: Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci USA. 89:246–250. 1992. View Article : Google Scholar : PubMed/NCBI
8	Putnins EE, Firth JD, Lohachitranont A, Uitto VJ and Larjava H: Keratinocyte growth factor (KGF) promotes keratinocyte cell attachment and migration on collagen and fibronectin. Cell Adhes Commun. 7:211–221. 1999. View Article : Google Scholar : PubMed/NCBI
9	Ornitz DM and Itoh N: Fibroblast growth factors. Genome Biol. 2:Reviews30052001. View Article : Google Scholar : PubMed/NCBI
10	Gillis P, Savla U, Volpert OV, et al: Keratinocyte growth factor induces angiogenesis and protects endothelial barrier function. J Cell Sci. 112:2049–2057. 1999.PubMed/NCBI
11	Ishiwata T, Friess H, Buchler MW, Lopez ME and Korc M: Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer. Am J Pathol. 153:213–222. 1998. View Article : Google Scholar : PubMed/NCBI
12	Cho K, Ishiwata T, Uchida E, et al: Enhanced expression of keratinocyte growth factor and its receptor correlates with venous invasion in pancreatic cancer. Am J Pathol. 170:1964–1974. 2007. View Article : Google Scholar : PubMed/NCBI
13	Kornmann M, Beger HG and Korc M: Role of fibroblast growth factors and their receptors in pancreatic cancer and chronic pancreatitis. Pancreas. 17:169–175. 1998. View Article : Google Scholar : PubMed/NCBI
14	Siddiqi I, Funatomi H, Kobrin MS, Friess H, Buchler MW and Korc M: Increased expression of keratinocyte growth factor in human pancreatic cancer. Biochem Biophys Res Commun. 215:309–315. 1995. View Article : Google Scholar : PubMed/NCBI
15	Zang XP, Lerner M, Brackett D and Pento JT: Influence of KGF on the progression of pancreatic cancer. Anticancer Res. 29:3417–3420. 2009.PubMed/NCBI
16	Oelmann E, Haghgu S, Kulimova E, et al: Influence of keratinocyte growth factor on clonal growth of epithelial tumor cells, lymphoma and leukemia cells and on sensitivity of tumor cells towards 5-fluorouracil in vitro. Int J Oncol. 25:1001–1012. 2004.PubMed/NCBI
17	Finch PW and Rubin JS: Keratinocyte growth factor expression and activity in cancer: implications for use in patients with solid tumors. J Natl Cancer Inst. 98:812–824. 2006. View Article : Google Scholar : PubMed/NCBI
18	Zang XP and Pento JT: Keratinocyte growth factor-induced motility of breast cancer cells. Clin Exp Metastasis. 18:573–580. 2000. View Article : Google Scholar : PubMed/NCBI
19	Zang XP, Bullen EC, Manjeshwar S, Jupe ER, Howard EW and Pento JT: Enhanced motility of KGF-transfected breast cancer cells. Anticancer Res. 26:961–966. 2006.PubMed/NCBI
20	Zang XP, Siwak DR, Nguyen TX, Tari AM and Pento JT: KGF-induced motility of breast cancer cells is dependent on Grb2 and Erk1,2. Clin Exp Metastasis. 21:437–443. 2004. View Article : Google Scholar : PubMed/NCBI
21	Beauchamp RD, Lyons RM, Yang EY, Coffey RJ Jr and Moses HL: Expression of and response to growth regulatory peptides by two human pancreatic carcinoma cell lines. Pancreas. 5:369–380. 1990. View Article : Google Scholar : PubMed/NCBI
22	Grose R and Dickson C: Fibroblast growth factor signaling in tumorigenesis. Cytokine Growth Factor Rev. 16:179–186. 2005. View Article : Google Scholar : PubMed/NCBI
23	Korc M and Friesel RE: The role of fibroblast growth factors in tumor growth. Curr Cancer Drug Targets. 9:639–651. 2009. View Article : Google Scholar : PubMed/NCBI